Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000222935 | SCV000272857 | uncertain significance | not specified | 2015-03-20 | criteria provided, single submitter | clinical testing | The p.His5256Gln variant in TTN has been identified by our laboratory in 1 Black adolescent with DCM and in 12/66530 European chromosomes by the Exome Aggregati on Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs138826545). Computa tional prediction tools and conservation analysis are limited or unavailable for this variant. In summary, the clinical significance of the p.His5256Gln variant is uncertain. |
Fulgent Genetics, |
RCV002494577 | SCV002776485 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J; Tibial muscular dystrophy; Myopathy, myofibrillar, 9, with early respiratory failure; Early-onset myopathy with fatal cardiomyopathy; Hypertrophic cardiomyopathy 9 | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000222935 | SCV001925273 | benign | not specified | no assertion criteria provided | clinical testing | ||
Diagnostic Laboratory, |
RCV000997559 | SCV001963574 | likely benign | not provided | no assertion criteria provided | clinical testing |